Novelos, Lee's Pharmaceutical deal

NVLT granted Lee's exclusive Chinese and Taiwanese rights to develop and commercialize NOV-002 to treat cancer and NOV-205 to treat hepatitis. NVLT will receive an undisclosed upfront payment and is e...